SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte ...
8h
I'm a UK mid-cap fund manager and these are three companies I've backed to succeed around the world
Investors are shunning Trump's America and giving markets like the UK a fresh look; Labour's inheritance tax raid on family farms and businesses is 'unlaw ...
A Dallas-based biotech company called Colossal Biosciences says it has produced “de-extinct” dire wolf pups using ...
Livestock breeders could soon have more tools to improve the health and quality of their animals, thanks to a recent study ...
In a single experiment, scientists can decipher the entire genomes of many patient samples, animal models, or cultured cells.
The push to revive extinct animals is accelerating, but scientists disagree about whether gene-edited species count as true "de-extinction." ...
Even with a major export market disappearing early in the year, the U.S. bovine genetics industry proved its resilience in ...
Subscribe to the Veterinary Apothecary newsletter on LinkedIn. Federal Approvals. FDA approves first and only second-generation Janus kinase inhibitor. Atinvicitinib tablets (Nume ...
Resurrect Bio and Corteva partner to restore corn’s natural disease resistance using AI-driven genetic discovery and screening tools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results